References
- Holaday J W. Cardiovascular effects of endogenous opiate systems. Ann. Rev. Pharmacol. Toxicol 1983; 23: 541–594
- Kunos G, Farsang C, Ramirez-Gonzalez M D. β-endorphin: possible involvement in the antihypertensive effect of central α -receptor activation. Science 1981; 211: 82–84
- Naranjo J R, Urdin M C, Fuentes J A. Further evidence on the central β-endorphin mediation in the antihypertensive effect of clonidine. Neurosci. Let 1982; S10: S345
- Petty M A, Sitsen J MA, de Jong W. β-endorphin, an endogenous depressor agent in the rat. Clin. Sci 1981; 61: 339s–342s
- Lemaire I, Tseng S, Lemaire S. Systemic administration of β-endorphin: potent hypotensive effect involving a serotoner gic pathway. Proc. Natl. Acad. Sci 1978; 75: 6240–6242
- Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β -endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 1977; 197: 1367–1369
- Bennet T, Gardiner S M. Corticosteroid involvement in the changes in noradrenergic responsiveness of tissues from rats made hypertensive by short-term isolation. Br. J. Pharmac 1978; 64: 129–136
- Russel J, Bass P, Goldberg L I, Schuster C R, Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Europ. J. Pharmacol 1982; 78: 255–261
- Giles T D, Sander E. Mechanism of the cardiovascular response to systemic intravenous administration of leucineenkephalin in concious dog. Peptides 1983; 4: 171–175